Nevro Corp.

Headquartered in Redwood City, California, Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10 therapy. The Nevro® Senza® SCS system received CE Mark in 2010, TGA Approval in 2011, FDA Approval in 2015, and is commercially available in Europe, Australia, and the United States.
Company Growth (employees)
Type
Public
HQ
Redwood City, US
Founded
2006
Size (employees)
518 (est)
Website
nevro.com
Nevro Corp. was founded in 2006 and is headquartered in Redwood City, US

Nevro Corp. Office Locations

Nevro Corp. has an office in Redwood City
Redwood City, US (HQ)
1800 Bridge Pkwy

Nevro Corp. Financials and Metrics

Nevro Corp. Financials

Nevro Corp.'s revenue was reported to be $68.4 m in Q1, 2017
USD

Revenue (Q1, 2017)

68.4 m

Gross profit (Q1, 2017)

46.4 m

Gross profit margin (Q1, 2017), %

68%

Net income (Q1, 2017)

(14.5 m)

EBIT (Q1, 2017)

(13.1 m)

Market capitalization (19-Oct-2017)

2.7 b

Cash (31-Mar-2017)

19.2 m
Nevro Corp.'s current market capitalization is $2.7 b.
USDFY, 2014FY, 2015FY, 2016

Revenue

32.6 m69.6 m228.5 m

Revenue growth, %

114%228%

Cost of goods sold

11.3 m28.1 m75.4 m

Gross profit

21.3 m41.5 m153.1 m
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

8.7 m9.7 m11.4 m15.4 m41.7 m55.4 m60.9 m68.4 m

Cost of goods sold

2.7 m3.9 m5.5 m6 m15.7 m18.8 m19.2 m22.1 m

Gross profit

5.9 m5.8 m5.9 m9.4 m26 m36.6 m41.7 m46.4 m

Gross profit Margin, %

68%60%52%61%62%66%68%68%
USDFY, 2014FY, 2015FY, 2016

Cash

25.3 m87 m41.4 m

Accounts Receivable

22.5 m52.8 m

Inventories

62.4 m85.2 m

Current Assets

201.1 m282.6 m420.3 m
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

14.5 m22 m58.7 m87.6 m48.8 m50.7 m42.7 m19.2 m

Inventories

12.1 m18.2 m26.4 m42.7 m67.6 m68.1 m73.4 m84.7 m

Current Assets

53.5 m187.8 m291.5 m279.2 m265.9 m402.5 m408.9 m407.4 m

PP&E

289 k1.2 m2.8 m5.7 m5.9 m6.7 m7.6 m7.4 m
USDFY, 2014FY, 2015FY, 2016

Net Income

(30.7 m)(67.4 m)(31.8 m)

Depreciation and Amortization

96 k614 k1.7 m

Accounts Receivable

167 k(16.2 m)(32.2 m)

Inventories

(5.5 m)(49.4 m)(27 m)
USDQ3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(7.9 m)(14.1 m)(19.7 m)(19.5 m)(9.3 m)(8.8 m)(3.9 m)(14.5 m)

Inventories

67.6 m68.1 m73.4 m84.7 m

Accounts Payable

3.5 m8.2 m7.3 m12.9 m11.8 m13.1 m13.1 m12.1 m
USDY, 2017

Revenue/Employee

132.1 k

Financial Leverage

1.7 x
Show all financial metrics

Nevro Corp. Operating Metrics

FY, 2016

Patents Issued

132

Patents Pending

101

Trademarks

16
Show all operating metrics

Nevro Corp. Market Value History

Traffic Overview of Nevro Corp.

Nevro Corp. Online and Social Media Presence

Nevro Corp. Company Life and Culture

You may also be interested in